BMY · Bristol Myers Squibb Co · Documents

Mar 23

Annual report to holders ARS

Annual report to holders

Mar 23

Proxy statement DEFA14A

Proxy statement

Feb 28

Current report 8-K Events of Feb 23

Other events

Feb 14

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $46.16B ▼ 0.5% Net income $6.33B ▼ 9.5% Diluted EPS $2.95 ▼ 5.4%

Feb 2

Current report 8-K

Financial results, Regulation FD disclosure

Feb 2

Earnings call

Q4 2022 earnings call

Jan 31

Current report 8-K Events of Jan 29

Director or officer change, or executive pay

Jan 9

Current report 8-K

Regulation FD disclosure

Oct 26

Current report 8-K Events of Oct 25

Financial results, Regulation FD disclosure

Oct 26

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $11.22B ▼ 3.5% Net income $1.61B ▲ 3.9% Diluted EPS $0.75 ▲ 8.7%

Oct 26

Earnings call

Q3 2022 earnings call

Aug 16

Tender offer SC TO-T/A

Tender offer

Aug 9

Tender offer SC TO-T/A

Tender offer

Jul 27

Current report 8-K

Financial results, Regulation FD disclosure

Jul 27

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $11.89B ▲ 1.6% Net income $1.42B ▲ 34.7% Diluted EPS $0.66 ▲ 40.4%

Jul 27

Earnings call

Q2 2022 earnings call

Jul 19

Tender offer SC TO-T/A

Tender offer

Jul 1

Tender offer SC TO-T/A

Tender offer

Jun 17

Tender offer SC TO-T

Tender offer

Jun 15

Current report 8-K Events of Jun 14

Director or officer change, or executive pay

Jun 3

Tender offer SC TO-C

Tender offer

May 5

Current report 8-K Events of May 3

Shareholder vote results

Apr 29

Current report 8-K

Financial results, Regulation FD disclosure

Apr 29

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $11.65B ▲ 5.2% Net income $1.28B ▼ 36.8% Diluted EPS $0.59 ▼ 33.7%

Apr 29

Earnings call

Q1 2022 earnings call

Apr 20

Proxy statement DEFA14A

Proxy statement

Apr 18

Current report 8-K

Financial results

Mar 24

Proxy statement DEF 14A Meeting May 3, 2022

Proxy statement

Mar 24

Proxy statement DEFA14A

Proxy statement

Mar 17

Current report 8-K Events of Mar 14

Director or officer change, or executive pay

Mar 3

Current report 8-K Events of Mar 1

Other events

Mar 2

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation

Feb 24

Current report 8-K Events of Feb 18

Other events

Feb 22

Current report 8-K Events of Feb 15

Entered into a material agreement, Other events

Feb 15

Current report 8-K

Other events

Feb 9

Current report 8-K Events of Feb 8

Other events

Feb 9

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $46.39B ▲ 9.1% Net income $6.99B Diluted EPS $3.12

Feb 4

Earnings call

Q4 2021 earnings call

Feb 4

Current report 8-K

Financial results, Regulation FD disclosure

Jan 10

Current report 8-K

Regulation FD disclosure

Dec 13

Registration statement S-3ASR

Registration statement

Nov 16

Current report 8-K

Regulation FD disclosure

Oct 27

Earnings call

Q3 2021 earnings call

Oct 27

Current report 8-K

Financial results, Regulation FD disclosure

Oct 27

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $11.62B ▲ 10.3% Net income $1.55B ▼ 17.4% Diluted EPS $0.69 ▼ 15.9%

Aug 9

Current report 8-K Events of Aug 3

Director or officer change, or executive pay

Jul 28

Earnings call

Q2 2021 earnings call

Jul 28

Current report 8-K

Financial results, Regulation FD disclosure

Jul 28

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $11.7B ▲ 15.5% Net income $1.06B Diluted EPS $0.47

May 20

Current report 8-K Events of May 14

Director or officer change, or executive pay